Liminatus Pharma, Inc.

financial.report · SEC EDGAR

This page reproduces a recorded source event. It is not a live quote, forecast, recommendation or legal conclusion.

Event type

financial.report

Occurred

2025-09-30

Reported

2025-11-14

Disclosure lag

45 days

Context

links are based on the recorded entity type

Field	Recorded value
Entity	Liminatus Pharma, Inc.
Source	SEC EDGAR ↗
News section	Unclassified
Source identifier	companyfacts/CIK0001971387/2026-07-26
Source-linked related entities	None recorded
Event ID	#51298

Related recorded events

same canonical or source-linked entity relations

Reported	Type	Event	Source
2026-09-29	New filing	Event #1193912	SEC EDGAR
2026-08-18	New filing	Event #860347	SEC EDGAR
2026-08-14	New filing	Event #739607	SEC EDGAR
2026-07-30	New filing	Event #170354	SEC EDGAR
2026-07-24	New filing	Event #19115	SEC EDGAR
2026-07-13	New filing	Event #22766	SEC EDGAR
2026-07-06	New filing	Event #24212	SEC EDGAR
2026-05-15	financial.report	Event #51299	SEC EDGAR

Recorded payload

JSON payload as stored after parsing

{
  "accession": "0001104659-25-111651",
  "canonical_covered": 9,
  "canonical_total": 12,
  "fiscal_period": "Q3",
  "fiscal_year": 2025,
  "form": "10-Q",
  "mapped_tag_share": 0.09345794392523364,
  "metrics": {
    "earnings_per_share_basic": -0.07,
    "earnings_per_share_diluted": -0.07,
    "net_income": -1823351,
    "operating_income": -701170,
    "shareholders_equity": -1645763,
    "shares_outstanding": 27064633,
    "total_assets": 1342409,
    "total_liabilities": 2988172
  },
  "metrics_reported": 8,
  "period_end": "2025-09-30"
}

Evidence-based analysis

facts, provenance and explicit model coverage

Descriptive evidence from the stored source record; it is not advice, a forecast or a legal conclusion.

Dimension	Status / value	Method or boundary
What happened	not_covered	The source record has no short title or summary.
When	source_backed · reported 2025-11-14	Occurred 2025-09-30. Source-record timestamps; no timezone or event time is inferred.
Affected entities	resolved · Liminatus Pharma, Inc. · 0 related	Canonical primary entity and stored related_entity_ids only.
Event classification	financial · financial.report	canonical event type plus source-provided category; no sentiment or impact is inferred
Entity linking	resolved	Canonical entity resolved during ingestion
Deduplication	applied	unique source event key at ingestion
Source trust	high · terms allowed	Source registry metadata
Sentiment	not_covered	No sentiment model output is published for this record.
Market reaction	not_covered	Requires licensed quote, candle and volume observations for the affected instrument.
Historical analogs	not_covered	Requires an audited event-cluster corpus and matching methodology.
Impact mechanism	not_covered	No causal market-impact model is published for this record.
Related risks	not_covered	Risk implications require an audited instrument/entity exposure model.
Instrument linkage	not_covered	No instrument relation is inferred from an entity event; licensed instrument mapping is required.

Source: SEC EDGAR · as of 2025-11-14T00:00:00Z